Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Mol Psychiatry. 2012 Nov 20;19(1):10.1038/mp.2012.157. doi: 10.1038/mp.2012.157

Table 1. Relevant datasets.

N
Dataset case
phenotype
markers
examined
cases controls
+ family
members
initial use overlap with other sets
SGENE-plus GWAS SZ 314,868 2,663 13,498 Stefansson15 no
SGENE-plus+ISC+MGS SZ 1,500 7,946 19,036 Stefansson15 includes SGENE-plus
GWAS
primary schizoprenia
follow-up
SZ 39 9,246 22,356 Steinberg14 no
primary psychosis
follow-up
SZ, BP, rel 39 18,583 69,324 this work includes primary
schizophrenia follow-up
secondary follow-up SZ 8; 11 1,014 1,144 Steinberg14 no

SZ, schizophrenia; BP, bipolar disorder; rel, related psychoses 1eight markers were examined in this set in the previous work14, an additional marker is genotyped in the current work